The Drug Supply Chain Security Act (DSCSA) requires US pharmaceutical supply chain actors to prove that they only interact with trading partners that are “authorized”. Trading partners are “authorized” when they hold state licenses valid at the time of trading.
Proof of electronically authorized status is required in every Saleable Return Verification process where wholesalers and their customers (dispensers such as hospitals, pharmacies and other points-of-dispensing) must be able to verify the validity of drugs and be able to uniformly identify products as legitimate or illegitimate. To check the counterparties’ “authorized” status, pharma companies can use the identity wallet technology.
Spherity is working together with global pharmaceutical manufacturers, wholesalers, distributors, the Healthcare Distribution Alliance and other solution providers to develop a production-grade solution for the Authorized Trading Partner legislation by Autumn 2020. Spherity’s Cloud Identity Wallet enables the exchange and verification of electronic state licenses.
